Epidemiologic studies of beta agonists and asthma deaths

Epidemiol Rev. 1998;20(2):173-86. doi: 10.1093/oxfordjournals.epirev.a017979.

Authors

N Pearce¹, M J Hensley

Affiliation

¹ Wellington Asthma Research Group, Department of Medicine, Wellington School of Medicine, New Zealand.

PMID: 9919437
DOI: 10.1093/oxfordjournals.epirev.a017979

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Adolescent
Adrenergic beta-Agonists / adverse effects*
Adrenergic beta-Agonists / therapeutic use
Adult
Asthma / chemically induced
Asthma / mortality*
Bronchodilator Agents / adverse effects*
Bronchodilator Agents / therapeutic use
Child
Child, Preschool
Fenoterol / adverse effects*
Fenoterol / therapeutic use
Humans
Isoproterenol / adverse effects*
Isoproterenol / therapeutic use
New Zealand / epidemiology
Saskatchewan / epidemiology

Substances

Adrenergic beta-Agonists
Bronchodilator Agents
Fenoterol
Isoproterenol